4.5 x 5.0mm SHORT® Implant receives FDA clearance and CE mark.
Introduction of the Universal Abutment System.
Bicon introduces its keyless Guided Surgery System.
3.0 x 6.0mm NARROW® and SHORT® Implant receives FDA clearance and CE mark.
Introduction of TRINIA®, the metal-free dental CAD/CAM solution.
Fabrication of fully retrievable and screwless IAC® restorations utilizing CAD/CAM technology and metal- free materials.
5.0mm SHORT® Implants, 3.0 x 8.0mm NARROW® Implants and the MAX 2.5® Implant System receive CE mark.
3.0 x 8.0mm NARROW® Implant receives FDA clearance.
Bicon’s 25th Anniversary.
MAX 2.5® Implant System, 4.0 x 5.0mm, and 4.0 x 6.0mm SHORT® Implant receive FDA clearance.
Completion of Bicon's state-of-the-art clinical and teaching facility.
4.5 x 6.0mm SHORT® Implant is introduced and receives FDA clearance.
Bicon celebrates the 20-year anniversary of its implant design.
Bicon introduces the Brevis® Overdenture System.
A new formulation of SynthoGraft® pure phase Beta-Tricalcium Phosphate is introduced.
5.0 x 6.0mm SHORT® Implant is introduced and receives FDA clearance.
FIRST Integrated Abutment Crown® (IAC) as well as the promotion of extra oral cementation of crowns.
6.0 x 8.0mm implant is introduced and receives FDA clearance.
Clinical studies begin for the shortest implant available on the market today: Bicon’s 5.7mm SHORT® Implant.
Driskell introduces the Titanodont implant, made of titanium alloy (Ti6Al4V-ELI) incorporating the same design features as the Synthodont.
FIRST Mechanically textured and acid etched bone/implant surfaces.
FIRST Complete interchangeability of abutment diameters, providing sensible biological width and offering the concept now being described as platform switching.
FIRST Locking taper implant to abutment connection providing 360˚ of universal abutment positioning.
Thomas Driskell initiates his dental implant research.
US Army Medical Research and Development Command Dental Research Division funds the development of a free standing single tooth replacement implant that could be placed into a fresh extraction site, and the development of synthetic bone grafting materials for the repair of avulsive wounds.